Evidence map›Paper›PMID 28764644›Full record

ArticleBMC bioinformatics2017

Variable selection for disease progression models: methods for oncogenetic trees and application to cancer and HIV.

Katrin Hainke, Sebastian Szugat, Roland Fried, Jörg Rahnenführer

Abstract read
In one paragraph

Article in BMC bioinformatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Modelling cancer progression using Mutual Hazard Networks.Bioinformatics (Oxford, England) · 2020
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katrin HainkeDepartment of Statistics, TU Dortmund University, Dortmund, 44221, Germany.
Sebastian SzugatDepartment of Statistics, TU Dortmund University, Dortmund, 44221, Germany.
Roland FriedDepartment of Statistics, TU Dortmund University, Dortmund, 44221, Germany.
Jörg RahnenführerDepartment of Statistics, TU Dortmund University, Dortmund, 44221, Germany. rahnenfuehrer@statistik.tu-dortmund.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDisease progression models are important for understanding the critical steps during the development of diseases. The models are imbedded in a statistical framework to deal with random variations due to biology and the sampling process when observing only a finite population. Conditional probabilities are used to describe dependencies between events that characterise the critical steps in the disease process. Many different model classes have been proposed in the literature, from simple path models to complex Bayesian networks. A popular and easy to understand but yet flexible model class are oncogenetic trees. These have been applied to describe the accumulation of genetic aberrations in cancer and HIV data. However, the number of potentially relevant aberrations is often by far larger than the maximal number of events that can be used for reliably estimating the progression models. Still, there are only a few approaches to variable selection, which have not yet been investigated in detail.

resultsWe fill this gap and propose specifically for oncogenetic trees ten variable selection methods, some of these being completely new. We compare them in an extensive simulation study and on real data from cancer and HIV. It turns out that the preselection of events by clique identification algorithms performs best. Here, events are selected if they belong to the largest or the maximum weight subgraph in which all pairs of vertices are connected.

conclusionsThe variable selection method of identifying cliques finds both the important frequent events and those related to disease pathways.

Indexed as

Disease ProgressionModels, BiologicalAlgorithmsCarcinogenesisCell Transformation, NeoplasticComputer SimulationGlioblastomaHIV InfectionsHumansModels, StatisticalNeoplasmsProbabilityDisease progression modelOncogenetic treeVariable selection

Identifiers

PMID28764644
PMCPMC5539896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.